Education
About Us
Working with TipRanks
Follow Us
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
RESEARCH TOOLSreports
Total Valuation
Shanghai Junshi Biosciences Co., Ltd. Class H has a market cap or net worth of HK$32.35B. The enterprise value is HK$25.93B.
Market CapHK$32.35B
Enterprise ValueHK$25.93B
Share Statistics
Shanghai Junshi Biosciences Co., Ltd. Class H has 219,295,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,295,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Junshi Biosciences Co., Ltd. Class H’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -14.79%.
Return on Equity (ROE)-0.22
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-14.79%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee755.75K
Profits Per Employee-496.87K
Employee Count2,578
Asset Turnover0.18
Inventory Turnover0.70
Valuation Ratios
The current PE Ratio of Shanghai Junshi Biosciences Co., Ltd. Class H is -8.37. Shanghai Junshi Biosciences Co., Ltd. Class H’s PEG ratio is -0.36.
PE Ratio-8.37
PS Ratio0.00
PB Ratio2.31
Price to Fair Value1.83
Price to FCF-12.00
Price to Operating Cash Flow-9.45
PEG Ratio-0.36
Income Statement
In the last 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H had revenue of 1.95B and earned -1.28B in profits. Earnings per share was -1.30.
Revenue1.95B
Gross Profit1.54B
Operating Income-1.34B
Pretax Income-1.36B
Net Income-1.28B
EBITDA-935.50M
Earnings Per Share (EPS)-1.30
Cash Flow
In the last 12 months, operating cash flow was -1.43B and capital expenditures -478.70M, giving a free cash flow of -863.76M billion.
Operating Cash Flow-1.43B
Free Cash Flow-863.76M
Free Cash Flow per Share-3.94
Dividends & Yields
Shanghai Junshi Biosciences Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.63
52-Week Price Change75.29%
50-Day Moving Average16.06
200-Day Moving Average13.60
Relative Strength Index (RSI)64.95
Average Volume (3m)5.30M
Important Dates
Shanghai Junshi Biosciences Co., Ltd. Class H upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateApr 26, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Shanghai Junshi Biosciences Co., Ltd. Class H as a current ratio of 1.72, with Debt / Equity ratio of 50.01%
Current Ratio1.72
Quick Ratio1.48
Debt to Market Cap0.27
Net Debt to EBITDA-0.46
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H has paid 22.55M in taxes.
Income Tax22.55M
Effective Tax Rate-0.02
Enterprise Valuation
Shanghai Junshi Biosciences Co., Ltd. Class H EV to EBITDA ratio is -11.91, with an EV/FCF ratio of -5.25.
EV to Sales5.72
EV to EBITDA-11.91
EV to Free Cash Flow-5.25
EV to Operating Cash Flow-7.77
Balance Sheet
Shanghai Junshi Biosciences Co., Ltd. Class H has HK$2.93B in cash and marketable securities with ¥2.93B in debt, giving a net cash position of -HK$1.82M billion.
Cash & Marketable SecuritiesHK$2.93B
Total Debt¥2.93B
Net Cash-HK$1.82M
Net Cash Per Share>-HK$0.01
Tangible Book Value Per ShareHK$5.51
Margins
Gross margin is 78.92%, with operating margin of -68.72%, and net profit margin of -65.75%.
Gross Margin78.92%
Operating Margin-68.72%
Pretax Margin-69.68%
Net Profit Margin-65.75%
EBITDA Margin-48.02%
EBIT Margin-62.21%
Analyst Forecast
The average price target for Shanghai Junshi Biosciences Co., Ltd. Class H is HK$12.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$12.00
Price Target Upside-43.79% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast25.96%
EPS Growth Forecast39.58%